Eisai is officially the place to leave

I'm not in sales. Home office. Subjected daily to the torture right in my face. Get out while you can. !

 

Hard to believe the lights are still on in that place.

 

Eisai. Funny.

 

one of the Philly reps left. She's a huge loss.

 

Oncology or Neuro?

 

Oncology.

 

fake news

 

STFU, Donny.

 

thats MR Donny to you

 

Eisai is where you go to START your career in Oncology or where you END it. Enough said.

 

AS did the dude.

 

Still true!

 

Alex did the dude.

 

Did Shaji do the same dude

 

LOL, we knew about the failure of the challenger model in 2014 when we got intelligence on your epilepsy franchise! UCB has wiped the floor clean with your A**!

 

What an absolute joke of a business franchise with their disastrous launch and pathetic sales of Fyckcompa, Bumzel and Zonegranny.

UCB has wiped the floor clean with Eisai's tight ass (well tighter than a Japanese Eisai geisha rep with all the money the shareholders keep and refuse to invest in marketing budgets).

And now they have submitted for a pediatric label - good luck with sales on that....oh wowowow, what's your differentiation, once daily to improve compliance at the risk of inducing aggression and suicide aggression?

• Patients treated with perampanel had a significantly greater reduction in all-cause hospitalizations compared to those treated with lacosamide, (25.3% vs 30.3%; p=0.0010; respectively). A similar result was seen for epilepsy-related hospitalizations (a reduction of 19.6% vs. 22.6%; p=0.0376, perampanel and lacosamide, respectively).
• Source: https://www.biospace.com/article/re...ated-with-adjunctive-fycompa-perampanel-ciii/

5% increase vs. Ucb's Vimpat (lacosamide) at the risk of aggression and suicide ideation????? What's the messaging you idiots? We increase reduction of seizures by 5% but we increase risk of aggression and suicide ideation???????

Here are the bad practices by Eisai:

Eisai Downplayed Drug's 'Homicidal' Side Effects, FDA Says
https://www.law360.com/articles/1093533/eisai-downplayed-drug-s-homicidal-side-effects-fda-says

Less than one week after issuing the Warning Letter to MannKind, on October 11, 2018, OPDP issued an Untitled Letter to Eisai Inc., regarding some oral statements made by a company sales representative in his capacity as an Eisai employee. According to the Letter, a report was submitted as part of a complaint to the OPDP Bad Ad Program, alleging that statements were made to healthcare professionals regarding Fycompa® (perampanel) tablets, providing evidence that the prescription “is intended for new uses for which it lacks approval, and for which its labeling does not provide adequate directions for use.”

F-You Eisai and your pathetic team. UCB! UCB! UCB! GW! GW! GW! Arvelle! Arvelle! Arvelle!

 

Heard CS ended up finally getting a job out West. Say hello endless KPI's and goodbye to anything meaningful or positive! What culture you had has now left the building. This guy is toxic and I am sure will be bringing aboard his merry band of idiots to help him count calls, find out important stuff like how many samples were left on each call, and the all important minimum number of lunch and learns per week! Keep those pencils handy and check all those important boxes. And don't be the one without a chair when the music stops as he won't be there to help but to point the finger at you as long as he doesn't look bad. That's all that matters to him.

 

NBG recent losses - LN, TC, JG, DL......more to come from what I am hearing!

 

guess they all are going to SK? What district will DL have? Then I’ll know whether to apply.

 

I dont know where they went. The culture here is toxic and there are many industry opportunities paying very well. Why would people stay here in this environment?